CKS2 and breast carcinoma: This concept was investigated in a mouse xenograft model where MCF-7 human breast cancer cells engineered to overexpress Cks2 were compared to their controls (with low Cks2 levels) for tumor growth responses after implantation into mammary fat pads of female nude mice.